Search research articles
Contact Us
Filters
Showing results (181-190 of 210) with videos related to
Page
of 21
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein
Alexandra A Abu-Shmais, Luqiang Guo, Ahmed Magady Khalil, et al.
The Journal of Pathology
|
November 15, 2011
Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome
Margot G F van Lier, Celine H M Leenen, Anja Wagner, et al.
European Journal of Pediatrics
|
August 20, 2020
Infliximab in young paediatric IBD patients: it is all about the dosing
Maria M E Jongsma, Dwight A Winter, Hien Q Huynh, et al.
Endoscopy
|
July 6, 2025
Two-sample fecal immunochemical testing as a tool to avert colonoscopy in symptomatic patients: a prospective multicenter cohort study
Sarah Moen, Pieter H A Wisse, Fleur Marijnissen, et al.
Clinical Pharmacokinetics
|
November 28, 2025
Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration
Q Zhao, M M E Jongsma, S A Vuijk, et al.
Journal of Crohn'S & Colitis
|
June 13, 2017
Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
Oren Ledder, Amit Assa, Arie Levine, et al.
NPJ Digital Medicine
|
May 15, 2025
Reducing outpatient visits for FIT-positive participants of colorectal cancer screening programs with home-based digital counselling
Fleur E Marijnissen, Elyse E C Rijnders, Merel M Tielemans, et al.
Cell Reports. Medicine
|
January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein
Alexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.
Journal of Crohn'S & Colitis
|
March 22, 2018
Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
Oren Ledder, Amit Assa, Arie Levine, et al.
Radiology
|
March 28, 2023
Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study
Max A A Ragusi, Bas H M van der Velden, Carla Meeuwis, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 210) with videos related to
Sort By:
Page
of 21
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein
Alexandra A Abu-Shmais, Luqiang Guo, Ahmed Magady Khalil, et al.
The Journal of Pathology
|
November 15, 2011
Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome
Margot G F van Lier, Celine H M Leenen, Anja Wagner, et al.
European Journal of Pediatrics
|
August 20, 2020
Infliximab in young paediatric IBD patients: it is all about the dosing
Maria M E Jongsma, Dwight A Winter, Hien Q Huynh, et al.
Endoscopy
|
July 6, 2025
Two-sample fecal immunochemical testing as a tool to avert colonoscopy in symptomatic patients: a prospective multicenter cohort study
Sarah Moen, Pieter H A Wisse, Fleur Marijnissen, et al.
Clinical Pharmacokinetics
|
November 28, 2025
Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration
Q Zhao, M M E Jongsma, S A Vuijk, et al.
Journal of Crohn'S & Colitis
|
June 13, 2017
Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
Oren Ledder, Amit Assa, Arie Levine, et al.
NPJ Digital Medicine
|
May 15, 2025
Reducing outpatient visits for FIT-positive participants of colorectal cancer screening programs with home-based digital counselling
Fleur E Marijnissen, Elyse E C Rijnders, Merel M Tielemans, et al.
Cell Reports. Medicine
|
January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein
Alexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.
Journal of Crohn'S & Colitis
|
March 22, 2018
Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
Oren Ledder, Amit Assa, Arie Levine, et al.
Radiology
|
March 28, 2023
Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study
Max A A Ragusi, Bas H M van der Velden, Carla Meeuwis, et al.
Page
of 21